Repligen | RGEN - Gewinn Vor Steuern

Aktienkurs
113.88
Täglich Wechseln
-3.73 -3.17%
Monatlich
-15.89%
Jährlich
-18.67%
Q1 Prognose
110.75




Gewinn Vor Steuern Veränderung Datum
Agilent USD 442M 1000K 2025-09
Align Technology USD 176.6M 81.86M 2025-12
Bio Techne USD 84.99M 107.85M 2025-09
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
Bruker USD -72.6M 73.1M 2025-09
Charles River Laboratories USD 170.03M 98.62M 2025-09
Danaher USD 1.08B 421M 2025-09
Dentsply International USD -230M 77M 2025-09
Exact Sciences USD -17.76M 17.7M 2025-09
General Electric Aerospace USD 2.85B 337M 2025-12
Henry Schein USD 137M 16M 2025-09
Illumina USD 220M 86M 2025-09
IQVIA Holdings USD 6.16B 5.84B 2025-09
Mettler Toledo International USD 269.24M 20.58M 2025-09
Myriad Genetics USD 4.6M 3.4M 2025-12
OraSure Technologies USD -18.43M 5.14M 2025-12
Pacific Biosciences Of California USD -40.17M 2.55M 2025-12
Pfizer USD 3.33B 290M 2025-09
Repligen USD 17.11M 10.25M 2025-09
Revvity USD 55.68M 115.97M 2025-09
Standard Biotools USD -22.03M 10.87M 2025-12
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Waters USD 170.12M 7.57M 2025-09
West Pharmaceutical Services USD 170.1M 8.1M 2025-09